Drug Shortage Report for MYLAN-LANSOPRAZOLE
Report ID | 90110 |
Drug Identification Number | 02353830 |
Brand name | MYLAN-LANSOPRAZOLE |
Common or Proper name | LANSOPRAZOLE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | LANSOPRAZOLE |
Strength(s) | 15MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 BT |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-07-29 |
Estimated end date | 2019-11-15 |
Actual end date | 2019-11-12 |
Shortage status | Resolved |
Updated date | 2019-11-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-29 | English | Compare |
v2 | 2019-07-29 | French | Compare |
v3 | 2019-07-30 | English | Compare |
v4 | 2019-08-30 | English | Compare |
v5 | 2019-08-30 | French | Compare |
v6 | 2019-11-12 | English | Compare |
v7 | 2019-11-12 | French | Compare |
v8 | 2019-11-13 | English | Compare |
Showing 1 to 8 of 8